GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

NCT01813422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

970

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

BIOLOGICAL: Evolocumab
DRUG: Placebo

Sponsor

Amgen